Renal Inflammation and Fibrosis: A Double-edged Sword

被引:151
作者
Black, Laurence M. [1 ]
Lever, Jeremie M. [1 ]
Agarwal, Anupam [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Nephrol, Nephrol Res & Training Ctr, Rm 647 THT,1720 2nd Ave South, Birmingham, AL 35226 USA
[2] Univ Alabama Birmingham, Dept Vet Affairs, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
acute kidney injury; cellular transdifferentiation; chemokines; chronic kidney disease; cytokines; extracellular matrix; fibrosis; growth factors; transforming growth factor-beta; TISSUE GROWTH-FACTOR; TUBULAR EPITHELIAL-CELLS; ACUTE KIDNEY INJURY; ISCHEMIA-REPERFUSION INJURY; TO-MESENCHYMAL TRANSITION; NECROSIS-FACTOR RECEPTOR; NF-KAPPA-B; TGF-BETA; HEME OXYGENASE-1; UP-REGULATION;
D O I
10.1369/0022155419852932
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Renal tissue injury initiates inflammatory and fibrotic processes that occur to promote regeneration and repair. After renal injury, damaged tissue releases cytokines and chemokines, which stimulate activation and infiltration of inflammatory cells to the kidney. Normal tissue repair processes occur simultaneously with activation of myofibroblasts, collagen deposition, and wound healing responses; however, prolonged activation of pro-inflammatory and pro-fibrotic cell types causes excess extracellular matrix deposition. This review focuses on the physiological and pathophysiological roles of specialized cell types, cytokines/chemokines, and growth factors, and their implications in recovery or exacerbation of acute kidney injury.
引用
收藏
页码:663 / 681
页数:19
相关论文
共 50 条
[31]   Epithelial Mesenchymal Transition: a double-edged sword [J].
Barriere, Guislaine ;
Fici, Pietro ;
Gallerani, Giulia ;
Fabbri, Francesco ;
Rigaud, Michel .
CLINICAL AND TRANSLATIONAL MEDICINE, 2015, 4
[32]   Bilirubin in wound healing: A double-edged sword [J].
Singla, Kshitij ;
Krishnan, Sarath M. P. ;
Bhattacharjya, Aklanta ;
Saxena, Rahul ;
Choudhary, Nitin ;
Goyal, Bela .
CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (08) :953-958
[33]   Autophagy-A double-edged sword in oncology [J].
Apel, Anja ;
Zentgraf, Hanswalter ;
Buechler, Markus W. ;
Herr, Ingrid .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (05) :991-995
[34]   Long non-coding RNAs: A double-edged sword in aging kidney and renal disease [J].
Wang, Yan-Ni ;
Yang, Chang-E ;
Zhang, Dan-Dan ;
Chen, Yuan-Yuan ;
Yu, Xiao-Yong ;
Zhao, Ying-Yong ;
Miao, Hua .
CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 337
[35]   Tumor necrosis factors (TNF): A double-edged sword [J].
Aggarwal, BB .
JOURNAL OF CLINICAL LIGAND ASSAY, 2000, 23 (03) :181-192
[36]   Autophagy in disease: a double-edged sword with therapeutic potential [J].
Martinet, Wim ;
Agostinis, Patrizia ;
Vanhoecke, Barbara ;
Dewaele, Michael ;
De Meyer, Guido R. Y. .
CLINICAL SCIENCE, 2009, 116 (9-10) :697-712
[37]   Innate lymphoid cells wield a double-edged sword [J].
Wills-Karp, Marsha ;
Finkelman, Fred D. .
NATURE IMMUNOLOGY, 2011, 12 (11) :1025-1027
[38]   Alendronate, a double-edged sword acting in the mevalonate pathway [J].
Tricarico, Paola Maura ;
Girardelli, Martina ;
Kleiner, Giulio ;
Knowles, Alessandra ;
Valencic, Erica ;
Crovella, Sergio ;
Marcuzzi, Annalisa .
MOLECULAR MEDICINE REPORTS, 2015, 12 (03) :4238-4242
[39]   NLRs in tumor chemotherapy resistance: A double-edged sword [J].
Sun, Lili ;
Zhu, Yanmei ;
Yuan, Yuan .
CHEMICO-BIOLOGICAL INTERACTIONS, 2025, 414
[40]   Hepatic Stellate Cell: A Double-Edged Sword in the Liver [J].
Luo, Nianan ;
Li, Jiangbin ;
Wei, Yu ;
Lu, Jianguo ;
Dong, Rui .
PHYSIOLOGICAL RESEARCH, 2021, 70 (06) :821-829